Research at Boston Children's Hospital

The research enterprise at Boston Children’s Hospital, comprising more than 3,000 researchers, is the world’s largest at a pediatric center. Our work is fueled by a deep understanding of disease coupled with world-class discovery platforms, including genetics and genomics, gene editing, bioinformatics, proteomics, bioengineering, image analysis, multiple animal models, biobanks and disease-specific stem cell lines. We have special expertise in rare disease discovery and see large, highly diverse patient populations.

michael rogers and danielle peterse

Find a Researcher

More than 3,000 researchers & scientific staff

Find a Researcher
find a Boston Children

Research Labs

1 million square feet of research space — and growing

Find a Center or Lab
explore Boston Children

Explore Research Topics

$388 million in total research funding FY2018 — #1 NIH funding for pediatric research

Find a Topic

A new frontier: Inside a custom drug

Dr. Yu and his team of scientists pulled off something unprecedented, something seemingly impossible. In the space of 10 months, they pinpointed Mila’s rare mutation, designed a drug to bypass it, engaged industry partners and FDA regulators, and launched a treatment trial — just for Mila.

Early encouraging results are reported in The New England Journal of Medicine. They could open a new path, showing it’s possible to create personalized genetic therapies for children with rare conditions — and to do so quickly.

Read more

Dr. Yu batten disease

Boston Children's Hospital Innovation

BCH Innovation News @BCH_Innovation 11/12/2019 8:19:18 PM
RT @tomsandora: Check out our study published today in @naturemedicine in which we provide genomic evidence that bacteria from probiotic ca…
BCH Innovation News @BCH_Innovation 11/12/2019 7:00:00 PM
Hope in the shadow of #LiFraumeni syndrome: Could liquid biopsy provide early cancer detection? Learn more:…
BCH Innovation News @BCH_Innovation 11/12/2019 5:00:01 PM
Patients with #sepsis are offered new insights to measure the function of their white blood cells:…
BCH Innovation News @BCH_Innovation 11/12/2019 3:00:00 PM
Repurposing nitazoxanide for #tuberculosis could enhance treatment without adding risk of #drugresistance:
BCH Innovation News @BCH_Innovation 11/12/2019 1:43:46 PM
RT @CancerResearch: CRI Fellow Dr. Zhaoqing Ba of @BostonChildrens co-authored a new paper in @Nature, which describes how one of the ways…
BCH Innovation News @BCH_Innovation 11/12/2019 1:43:33 PM
RT @HarvardCatalyst: 2018: Courses and training programs in #clinicalresearch trained 10,000 participants since 2009, & saw new high in num…
Building on our extraordinary leadership in pediatric science at Boston Children’s, we translate our findings — and those of others — to fundamentally change how disease is treated and cured.

David A. Williams, MD
Senior Vice President and Chief Scientific Officer